Belančić, A.; Kučan Štiglić, M.; Jelaković, A.; Pećin, I.; Jelaković, B.; Vitezić, D.
Utilization Trends of SGLT2 Inhibitors in Croatian Clinical Practice: Observational Analysis. Medicina 2026, 62, 286.
https://doi.org/10.3390/medicina62020286
AMA Style
Belančić A, Kučan Štiglić M, Jelaković A, Pećin I, Jelaković B, Vitezić D.
Utilization Trends of SGLT2 Inhibitors in Croatian Clinical Practice: Observational Analysis. Medicina. 2026; 62(2):286.
https://doi.org/10.3390/medicina62020286
Chicago/Turabian Style
Belančić, Andrej, Marta Kučan Štiglić, Ana Jelaković, Ivan Pećin, Bojan Jelaković, and Dinko Vitezić.
2026. "Utilization Trends of SGLT2 Inhibitors in Croatian Clinical Practice: Observational Analysis" Medicina 62, no. 2: 286.
https://doi.org/10.3390/medicina62020286
APA Style
Belančić, A., Kučan Štiglić, M., Jelaković, A., Pećin, I., Jelaković, B., & Vitezić, D.
(2026). Utilization Trends of SGLT2 Inhibitors in Croatian Clinical Practice: Observational Analysis. Medicina, 62(2), 286.
https://doi.org/10.3390/medicina62020286